Carboprost


Generic Medicine Info
Contraindications
Acute pelvic inflammatory disease; active cardiac, pulmonary, renal or hepatic disease.
Special Precautions
Patient w/ compromised (scarred) uteri; history of asthma, seizure disorders, DM, anaemia, glaucoma or raised intra-ocular pressure, HTN, hypotension, CV disease, hepatic disease, including jaundice or renal disease. Pregnancy and lactation. Patient Counselling This drug may cause syncope, dizziness and somnolence, if affected, do not drive or use machines. Monitoring Parameters Monitor for reductions in arterial-oxygen content in patients w/ cardiopulmonary disorders.
Adverse Reactions
Vomiting, diarrhoea, nausea, transient fever, flushing, increased BP, bronchospasm, dyspnoea, pulmonary oedema.
Drug Interactions
May potentiate effect of other oxytocics.
ATC Classification
G02AD04 - carboprost ; Belongs to the class of prostaglandins. Used to induce abortion or augment labour and to minimize blood loss from the placental site.
Disclaimer: This information is independently developed by CIMS based on carboprost from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in